<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>WARYHA, JOHN Progress Note</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">WARYHA, JOHN Progress Note</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">JOHN C WARYHA</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">February 6, 1952 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>WHITE</li><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>NOT HISPANIC OR LATINO</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Primary Home Address:<br/>2242 SANDSTONE CLIFT DR<br/>HENDERSON, NV 89044<br/><br/>Mobile Phone:  (702)914-7679<br/>Mobile Phone:  (702)914-7679<br/>Email:  JCWARY@YAHOO.COM<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">1976536 2.16.840.1.113883.3.623<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">ProgressNote_WARYHA_20240806_1210_51.650 2.16.840.1.113883.3.623</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">August 6, 2024, 12:10:51, MST </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Holavanahalli Keshava-Prasad of Comprehensive Cancer Center of Nevada</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/><br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">G2Carequality Interface, Comprehensive Cancer Center of Nevada</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">Siena Stephanie Horizon Ridge Twain<br/>Summerlin Southern Hills Northwest<br/>Las Vegas, NV 89128<br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">9937012 2.16.840.1.113883.19</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">OFFICE/OUTPATIENT ESTABLISHED MOD MDM 30-39 MIN</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From November 15, 2023  to November 15, 2023 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value"/></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Informant</span></td><td class="td_header_role_value">Holavanahalli Keshava-Prasad of Comprehensive Cancer Center of Nevada</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">McKesson Specialty Health</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">10101 Woodloch Forest<br/>The Woodlands, TX 77380, USA<br/><br/>Work Phone:  800 381 2637<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Assessment</a></li><li><a href="#id2">Allergies and Adverse Reactions</a></li><li><a href="#id3">Plan</a></li><li><a href="#id4">Reason for Visit</a></li><li><a href="#id5">Encounters</a></li><li><a href="#id6">Immunizations</a></li><li><a href="#id7">Diagnostic Results</a></li><li><a href="#id8">Medications</a></li><li><a href="#id9">Problems</a></li><li><a href="#id10">Vital Signs</a></li><li><a href="#id11">Notes Section</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Assessment</a></h3><div>See Clinical Notes section</div><h3><a name="id2" href="#toc">Allergies and Adverse Reactions</a></h3><div><table>
    <thead>
        <tr>
                            <th>Medication/Group Name</th>
                <th>Reaction</th>
                <th>Severity</th>
                <th>Date</th>
        </tr>
    </thead>
    <tbody>
                <tr ID="AlertOBS-1000">
                    <td colspan="4">No known allergies</td>
                </tr>
    </tbody>
</table>
</div><h3><a name="id3" href="#toc">Plan</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Value</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="CarePlanRef-1001">
						<td>11/15/2023</td>
						<td>APPOINTMENT</td>
						<td>OV 15 MIN</td>
				</tr>
				<tr ID="CarePlanRef-1002">
						<td>11/15/2023</td>
						<td>LABORDER</td>
						<td>Thyroglobulin panel</td>
				</tr>
				<tr ID="CarePlanRef-1003">
						<td>11/15/2023</td>
						<td>LABORDER</td>
						<td>CMP</td>
				</tr>
				<tr ID="CarePlanRef-1004">
						<td>11/15/2023</td>
						<td>LABORDER</td>
						<td>CBC w/ auto diff</td>
				</tr>
				<tr ID="CarePlanRef-1005">
						<td>11/15/2023</td>
						<td>LABORDER</td>
						<td>Thyroid panel</td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id4" href="#toc">Reason for Visit</a></h3><div>OV 15 MIN</div><h3><a name="id5" href="#toc">Encounters</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
		</tr>
	</thead>
	<tbody>
					<tr ID="EncounterDiagnosisRef-1006">
							<td>11/15/2023</td>
							<td>Primary malignant neoplasm of thyroid gland (disorder)</td>						
					</tr>
	</tbody>
</table>
</div><h3><a name="id6" href="#toc">Immunizations</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
				<th>Route</th>
				<th>Dose</th>
				<th>Instructions</th>
				<th>Refusal Reason</th>
				<th>Status</th>
		</tr>
	</thead>
	<tbody>
				<tr><td colspan="7">No data for this encounter</td></tr>
	</tbody>
</table>
</div><h3><a name="id7" href="#toc">Diagnostic Results</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Test</th>
				<th>Units</th>
				<th>Lower Limit</th>
				<th>Upper Limit</th>
				<th>Result</th>
				<th>Flag</th>
				<th>Comments</th>
				<th>Status</th>
				<th>Ordered By</th>
				<th>Specimen Source</th>
				<th>Lab Address</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="ResultOBS-1007">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>WBC</td>
						<td>x10E3/uL</td>
						<td>3.4</td>
						<td>10.8</td>
						<td>7.6</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1008">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>RBC</td>
						<td>x10E6/uL</td>
						<td>4.14</td>
						<td>5.8</td>
						<td>4.58</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1009">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>HGB</td>
						<td>g/dL</td>
						<td>13.0</td>
						<td>17.7</td>
						<td>15.5</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1010">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>HCT</td>
						<td>%</td>
						<td>37.5</td>
						<td>51.0</td>
						<td>46.5</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1011">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>MCV</td>
						<td>fL</td>
						<td>79.0</td>
						<td>97.0</td>
						<td>102</td>
						<td>High</td>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1012">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>MCH</td>
						<td>pg</td>
						<td>26.6</td>
						<td>33.0</td>
						<td>33.8</td>
						<td>High</td>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1013">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>MCHC</td>
						<td>g/dL</td>
						<td>31.5</td>
						<td>35.7</td>
						<td>33.3</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1014">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>RDW</td>
						<td>%</td>
						<td>11.6</td>
						<td>15.4</td>
						<td>12.2</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1015">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>PLT</td>
						<td>x10E3/uL</td>
						<td>150.0</td>
						<td>450.0</td>
						<td>183</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1016">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>Neu %</td>
						<td>%</td>
						<td/>
						<td/>
						<td>67</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1017">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>Lymphocyte %</td>
						<td>%</td>
						<td/>
						<td/>
						<td>21</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1018">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>Monocyte %</td>
						<td>%</td>
						<td/>
						<td/>
						<td>8</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1019">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>Eosinophil %</td>
						<td>%</td>
						<td/>
						<td/>
						<td>2</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1020">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>Basophil %</td>
						<td>%</td>
						<td/>
						<td/>
						<td>1</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1021">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>Neu # (ANC)</td>
						<td>x10E3/uL</td>
						<td>1.4</td>
						<td>7.0</td>
						<td>5.2</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1022">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>LY #</td>
						<td>x10E3/uL</td>
						<td>0.7</td>
						<td>3.1</td>
						<td>1.6</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1023">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>MO #</td>
						<td>x10E3/uL</td>
						<td>0.1</td>
						<td>0.9</td>
						<td>0.6</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1024">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>EO #</td>
						<td>x10E3/uL</td>
						<td>0.0</td>
						<td>0.4</td>
						<td>0.1</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1025">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>BA #</td>
						<td>x10E3/uL</td>
						<td>0.0</td>
						<td>0.2</td>
						<td>0.0</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1026">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>Granulocytes, immature</td>
						<td>%</td>
						<td/>
						<td/>
						<td>1</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1027">
						<td>02/14/2024</td>
						<td>CBC w/ auto diff</td>
						<td>IG #</td>
						<td>x10E3/uL</td>
						<td>0.0</td>
						<td>0.1</td>
						<td>0.0</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>WB</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1028">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>Glucose</td>
						<td>mg/dL</td>
						<td>70.0</td>
						<td>99.0</td>
						<td>117</td>
						<td>High</td>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1029">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>BUN</td>
						<td>mg/dL</td>
						<td>8.0</td>
						<td>27.0</td>
						<td>13</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1030">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>Creatinine</td>
						<td>mg/dL</td>
						<td>0.76</td>
						<td>1.27</td>
						<td>0.99</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1031">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>eGFR, mL/min/1.73</td>
						<td>mL/min/1.73</td>
						<td/>
						<td/>
						<td>81</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1032">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>BUN/Creatinine ratio</td>
						<td/>
						<td>10.0</td>
						<td>24.0</td>
						<td>13</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1033">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>Sodium</td>
						<td>mmol/L</td>
						<td>134.0</td>
						<td>144.0</td>
						<td>139</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1034">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>Potassium</td>
						<td>mmol/L</td>
						<td>3.5</td>
						<td>5.2</td>
						<td>4.1</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1035">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>Chloride</td>
						<td>mmol/L</td>
						<td>96.0</td>
						<td>106.0</td>
						<td>101</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1036">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>CO2</td>
						<td>mmol/L</td>
						<td>20.0</td>
						<td>29.0</td>
						<td>23</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1037">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>Calcium</td>
						<td>mg/dL</td>
						<td>8.6</td>
						<td>10.2</td>
						<td>9.3</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1038">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>Total protein</td>
						<td>g/dL</td>
						<td>6.0</td>
						<td>8.5</td>
						<td>6.6</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1039">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>Albumin</td>
						<td>g/dL</td>
						<td>3.8</td>
						<td>4.8</td>
						<td>4.3</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1040">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>Globulin</td>
						<td>g/dL</td>
						<td>1.5</td>
						<td>4.5</td>
						<td>2.3</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1041">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>A/G ratio</td>
						<td/>
						<td>1.2</td>
						<td>2.2</td>
						<td>1.9</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1042">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>Bilirubin, total</td>
						<td>mg/dL</td>
						<td>0.0</td>
						<td>1.2</td>
						<td>1.2</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1043">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>Alkaline phosphatase, IU/L</td>
						<td>IU/L</td>
						<td>44.0</td>
						<td>121.0</td>
						<td>61</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1044">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>AST/SGOT, IU/L</td>
						<td>IU/L</td>
						<td>0.0</td>
						<td>40.0</td>
						<td>19</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1045">
						<td>02/14/2024</td>
						<td>CMP</td>
						<td>ALT/SGPT, IU/L</td>
						<td>IU/L</td>
						<td>0.0</td>
						<td>44.0</td>
						<td>18</td>
						<td/>
						<td/>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1046">
						<td>02/14/2024</td>
						<td>Thyroglobulin antibody panel</td>
						<td>Thyroglobulin ab, IU/mL</td>
						<td>IU/mL</td>
						<td>0.0</td>
						<td>0.9</td>
						<td>&lt;1.0</td>
						<td/>
						<td>Thyroglobulin Antibody measured by Beckman Coulter Methodology
It should be noted that the presence of thyroglobulin antibodies
may not be pathogenic nor diagnostic, especially at very low
levels. The assay manufacturer has found that four percent of
individuals without evidence of thyroid disease or autoimmunity
will have positive TgAb levels up to 4 IU/mL.</td>
						<td>FINAL</td>
						<td/>
                        <td>SER</td>
                        <td>LABCORP, 2080 E Flamingo, Suite 115 LAS VEGAS NV 891190000  </td>
				</tr>
				<tr ID="ResultOBS-1047">
						<td>02/14/2024</td>
						<td/>
						<td>Lab Report</td>
						<td/>
						<td/>
						<td/>
						<td>See attached</td>
						<td/>
						<td/>
						<td/>
						<td/>
                        <td/>
                        <td/>
				</tr>
	</tbody>
</table>
</div><h3><a name="id8" href="#toc">Medications</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
				<th>Route</th>
				<th>Dose</th>
				<th>Frequency</th>
				<th>Instructions</th>
				<th>Start Date</th>
				<th>End Date</th>
				<th>Status</th>
		</tr>
	</thead>
	<tbody>
					<tr ID="MedicationOBS-1048">
							<td/>
							<td>Losartan-Hydrochlorothiazide Oral 50 mg-12.5 mg </td>
							<td>po</td>
							<td>1.0 </td>
							<td>daily</td>
							<td/>
							<td/>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1049">
							<td/>
							<td>Omega-3 Fatty Acids Oral </td>
							<td>po</td>
							<td> </td>
							<td>daily</td>
							<td/>
							<td/>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1050">
							<td/>
							<td>Metoprolol Oral 24 hr Tab (Succinate) </td>
							<td>po</td>
							<td>1.0 </td>
							<td>daily</td>
							<td/>
							<td/>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1051">
							<td>08/20/2024</td>
							<td>Thyrogen Kit (0.9 MG Vial) </td>
							<td>intramuscularly</td>
							<td>0.9 mg</td>
							<td>As Directed</td>
							<td/>
							<td>08/20/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1052">
							<td>08/19/2024</td>
							<td>Thyrogen Kit (0.9 MG Vial) </td>
							<td>intramuscularly</td>
							<td>0.9 mg</td>
							<td>As Directed</td>
							<td/>
							<td>08/19/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1053">
							<td>05/10/2023</td>
							<td>levothyroxine sodium 0.1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>every day</td>
							<td/>
							<td>05/10/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1054">
							<td>02/09/2023</td>
							<td>levothyroxine sodium 0.1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>every day</td>
							<td/>
							<td>02/09/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1055">
							<td>02/08/2023</td>
							<td>levothyroxine sodium 0.1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>every day</td>
							<td/>
							<td>02/08/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1056">
							<td>07/29/2022</td>
							<td>levothyroxine sodium 0.15 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>every day</td>
							<td/>
							<td>07/29/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1057">
							<td>06/07/2022</td>
							<td>Apixaban Oral </td>
							<td>PO</td>
							<td>1.0 TABLET(S)</td>
							<td>BID</td>
							<td/>
							<td>06/07/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1058">
							<td>03/04/2022</td>
							<td>Cholecalciferol Oral </td>
							<td>PO</td>
							<td>5000.0 UNIT</td>
							<td>daily</td>
							<td/>
							<td>03/04/2022</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1059">
							<td>11/24/2021</td>
							<td>Atorvastatin Oral </td>
							<td>PO</td>
							<td>1.0 TABLET(S)</td>
							<td>daily</td>
							<td/>
							<td>11/24/2021</td>
							<td/>
							<td>active</td>
					</tr>
	</tbody>
</table>
</div><h3><a name="id9" href="#toc">Problems</a></h3><div><table>
	<thead>
		<tr>
							<th>Diagnosis</th>
				<th>Status</th>
				<th>Date of Diagnosis</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="ProblemOBS-1060">
						<td>Primary malignant neoplasm of thyroid gland (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1061">
						<td>Nausea and vomiting (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1062">
						<td>Hypothyroidism (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1063">
						<td>Obesity (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
	</tbody>
</table>
</div><h3><a name="id10" href="#toc">Vital Signs</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Value</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="VitalSignsRef-1064">
						<td>11/15/2023</td>
						<td>
							Body Temperature
							
						</td>
						<td>97.10</td>
				</tr>
				<tr ID="VitalSignsRef-1065">
						<td>11/15/2023</td>
						<td>
							Heart Beat
							
						</td>
						<td>71.00</td>
				</tr>
				<tr ID="VitalSignsRef-1066">
						<td>11/15/2023</td>
						<td>
							Respiratory Rate
							
						</td>
						<td>18.00</td>
				</tr>
				<tr ID="VitalSignsRef-1067">
						<td>11/15/2023</td>
						<td>
							Oxygen Saturation
							
						</td>
						<td>92.00</td>
				</tr>
				<tr ID="VitalSignsRef-1068">
						<td>11/15/2023</td>
						<td>
							Intravascular Systolic
							
						</td>
						<td>127</td>
				</tr>
				<tr ID="VitalSignsRef-1069">
						<td>11/15/2023</td>
						<td>
							Intravascular Diastolic
							
						</td>
						<td>73</td>
				</tr>
				<tr ID="VitalSignsRef-1070">
						<td>11/15/2023</td>
						<td>
							Weight
							
						</td>
						<td>225.00</td>
				</tr>
				<tr ID="VitalSignsRef-1071">
						<td>11/15/2023</td>
						<td>
							Height
							
						</td>
						<td>66.00</td>
				</tr>
				<tr ID="VitalSignsRef-1072">
						<td>11/15/2023</td>
						<td>
							BMI
							
						</td>
						<td>36.32</td>
				</tr>
				<tr ID="VitalSignsRef-1073">
						<td>11/15/2023</td>
						<td>
							BSA
							
						</td>
						<td>2.10</td>
				</tr>
				<tr ID="VitalSignsRef-1074">
						<td>11/15/2023</td>
						<td>
							Pain Scale
							
						</td>
						<td>0.00</td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id11" href="#toc">Notes Section</a></h3><div>	<ul><li>
		        Follow Up Note - Keshava Prasad: 
		        <p>
		        		    <br/>
<br/>
3730 S. Eastern Avenue<br/>
Las Vegas, NV 89169<br/>
P: 702-952-3400 F: 702-952-3460<br/>
<br/>

<br/>
PATIENT: JOHN WARYHA

<br/>MRN: 1976536

<br/>DATE: 11/15/2023

<br/>DOB: 02/06/1952

<br/>ATTENDING PHYSICIAN: Holavanahalli Keshava Prasad, MD

<br/>
FOLLOW-UP NOTE<br/>
<br/>
<br/> HISTORY OF PRESENT ILLNESS- <br/>
<br/>
This is a pleasant 71-year-old Caucasian male patient.  He has history of obesity, hypertension hyperlipidemia and atrial fibrillation.  Is also had skin cancer and knee surgery.  He was admitted to Sunrise Hospital on 11/12/2021.  He had noticed a right neck mass initially about 2 months ago.  He went to the emergency department at Henderson Hospital initially and a CT scan showed a neck mass probably related to thyroid. the patient had been discharged and went to Sunrise Hospital on 11/12/2021.<br/>
He underwent tests including ultrasound of the thyroid which showed an enlarged heterogeneous hyperemic right thyroid lobe with adjacent tortuous solid lesions with apparent extension to the vein suggesting tumor thrombus and vessels small tumor protruding into the jugular vein.  Overall findings suggest malignant etiology.<br/>
<br/>
Patient underwent a thyroid mass biopsy on 11/17/2021.  The pathology showed tumor cells arranged in neoplastic follicles, with solid areas and scattered rare nuclear grooves.  TTF-1 is positive.  Findings consistent with follicular neoplasm including follicular carcinoma, follicular variant of papillary thyroid carcinoma and insular carcinoma.  Surgical excision recommended. <br/>
<br/>
 The patient was referred for evaluation and management of thyroid cancer.  He came for the initial visit on 11/24/2021 and then followed up.<br/>
<br/>


<br/>
<br/>
<br/> THERAPY- <br/>
<ol><li>The patient underwent total thyroidectomy on 2/21/22 with central nodal dissection, much more difficult than usual taking at least 3 hours longer than usual surgery. Right-sided modified radical neck dissection also done which also with small difficult than usual. Tracheal carcinoma resection with primary repair was done, tracheostomy.</li><li>Radioactive Iodine treatment 5/11/22</li></ol>
is on Synthroid and Vitamin D supplementation<br/>
<br/>
<br/>
<br/> INTERVAL HISTORY- <br/>
11/15/23<br/>
 <br/>
No hospitalization<br/>
Had colonoscopy 8/17/23<br/>
<br/>
CC: Thyroid cancer, lab and med review<br/>
<br/>
I examined the patient, reviewed, charts, meds and labs and discussed with nursing staff.<br/>
<br/>
<br/>
<br/> REVIEW OF SYSTEMS- <br/>
11/15/23<br/>
<br/>
Pt states he feels well<br/>
active<br/>
exercising and trying to lose weight<br/>
Tremors improved after decreasing Synthroid to 100mcg per day <br/>
<br/>
Hoarse voice much improved<br/>
no dysphagia<br/>
appetite better; and is trying to lose weight<br/>
the tremulousness is better after reducing L thyroxine<br/>
No nausea vomiting diarrhea fever chills abdominal pain<br/>
Weight : lost about 30 lbs and then stabilized<br/>
A 14 system review otherwise negative<br/>
History reviewed, updated and brought forward for continuity of care<br/>
<br/>
<br/>

<br/> PAST MEDICAL HISTORY- <br/>
Obesity, right-sided thyroid cancer, hypertension, hyperlipidemia, atrial fibrillation<br/>
Hypothyroidism<br/>
<br/>
<br/>
<br/> PAST SURGICAL HISTORY- <br/>
Thyroid biopsy, history of hernia operation, ACL repair and appendectomy<br/>
Total thyroidectomy  on 2/21/22 with central nodal dissection, much more difficult than usual taking at least 3 hours longer than usual surgery. Right-sided modified radical neck dissection also done which also with small difficult than usual. Tracheal carcinoma resection with primary repair was done, tracheostomy.<br/>
Pacemaker inserted by Dr. Kalla ; last checked 12/2022<br/>
<br/>
<br/>
<br/> FAMILY HISTORY- <br/>
Father died of pancreatic cancer<br/>
<br/>
Sister # 1: Alive and well, no past illness, age: 72 years.<br/>
Mother: Deceased, cause of death: congestive heart failure, age at death: 70 years.<br/>
Father: Deceased, cause of death: cancer, pancreatic cancer, age at death: 71 years.<br/>
<br/>
<br/>
<br/> SOCIAL HISTORY- <br/>
Patient is retired, married, lives with<br/>
No tobacco alcohol or drug abuse<br/>
<br/>
<br/>
<br/>
<br/> OB/GYN HISTORY- <br/>
<br/>
<br/>


<br/>
<br/> HEALTH MAINTENANCE- <br/>
Screenings: None reported<br/>
Immunizations:
<ul><li>Covid-19 vaccine (Moderna) (06/07/2022), Elsewhere</li><li>Pneumococcal vaccine (23 valent) (06/07/2022), Elsewhere</li></ul>
<br/>
Smoking Status: Smoking Tobacco : Never smoker; Smokeless Tobacco : none found; Vaping : none found<br/>
<br/>
<br/> ALLERGIES- <br/>


<br/>No known medication allergies<br/>
<br/>
<br/> MEDICATIONS- <br/>

<ul><li>Omega-3 Fatty Acids Oral 1,000 mg capsule</li><li>Cholecalciferol Oral 250 mcg (10,000 unit) capsule</li><li>Metoprolol Oral 24 hr Tab (Succinate)</li><li>Levothyroxine Oral 100 mcg tablet</li><li>Apixaban Oral 5 mg tablet</li><li>Atorvastatin Oral 40 mg tablet</li><li>Losartan-Hydrochlorothiazide Oral 50 mg-12.5 mg</li></ul>
<br/>
<br/>
<br/> VITAL SIGNS- <br/>
Blood pressure: 127/73, Sitting, L arm, Wrist, Pulse: 71, Temperature: 97.1 F, Respirations: 18, O2 sat: 92%, At Rest, Room Air, Pain Scale: 0, Height: 66 in, Weight: 225 lb, BSA: 2.1, BMI: 36.32 kg/m2<br/>
<br/>


<br/> PHYSICAL EXAM- 

<br/>
<br/>
<br/>
<br/>
<br/>
<br/>GENERAL:  The patient is alert and oriented x3<br/>
Vs noted<br/>
 HEENT:  Normocephalic/atraumatic.  PERRLA. Mucosa dry. <br/>
Trach site scar<br/>
Thyroidectomy scar<br/>
CHEST:  Clear lung fields. <br/>
CVS:  Heart sounds within normal limits.<br/>
ABDOMEN: Soft, nontender.  Liver and spleen not palpable<br/>
EXTREMITIES:  No significant edema.  Calves are supple.<br/>
NEUROLOGIC:  No focal deficits. The patient is anxious. <br/>
SKIN:  No rash or ecchymosis. 


<br/>


<br/>
<br/>
<br/> LAB DATA- <br/>

<table border="1">
	<tbody>
		<tr>
			<th align="left">LabResults</th>
			<td>11/08/2023</td>
			<td>08/16/2023</td>
			<td>08/08/2023</td>
			<td>04/26/2023</td>
			<td>04/12/2023</td>
			<td>03/20/2023</td>
		</tr>
		<tr>
			<th align="left">  CBC</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    WBC x 10^3/uL</td>
			<td>8.0</td>
			<td><br/>
			</td>
			<td>7.5</td>
			<td>5.9</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    RBC x 10^6/uL</td>
			<td>4.68</td>
			<td><br/>
			</td>
			<td>4.75</td>
			<td>4.67</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    HGB g/dL</td>
			<td>15.7</td>
			<td><br/>
			</td>
			<td>16.5</td>
			<td>16.2</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    HCT %</td>
			<td>46.7</td>
			<td><br/>
			</td>
			<td>48.0</td>
			<td>47.6</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    MCV fL</td>
			<td>100 (H)</td>
			<td><br/>
			</td>
			<td>101 (H)</td>
			<td>102 (H)</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    MCH pg</td>
			<td>33.5 (H)</td>
			<td><br/>
			</td>
			<td>34.7 (H)</td>
			<td>34.7 (H)</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    MCHC g/dL</td>
			<td>33.6</td>
			<td><br/>
			</td>
			<td>34.4</td>
			<td>34.0</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    RDW %</td>
			<td>12.7</td>
			<td><br/>
			</td>
			<td>12.3</td>
			<td>13.2</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    PLT x 10^3/uL</td>
			<td>208</td>
			<td><br/>
			</td>
			<td>191</td>
			<td>184</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Neu %</td>
			<td>69</td>
			<td><br/>
			</td>
			<td>66</td>
			<td>67</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Neu # (ANC) x 10^3/uL</td>
			<td>5.4</td>
			<td><br/>
			</td>
			<td>4.9</td>
			<td>4.0</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    MO # x 10^3/uL</td>
			<td>0.6</td>
			<td><br/>
			</td>
			<td>0.6</td>
			<td>0.5</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    EO # x 10^3/uL</td>
			<td>0.1</td>
			<td><br/>
			</td>
			<td>0.1</td>
			<td>0.1</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    BA # x 10^3/uL</td>
			<td>0.0</td>
			<td><br/>
			</td>
			<td>0.1</td>
			<td>0.0</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    IG # x 10^3/uL</td>
			<td>0.0</td>
			<td><br/>
			</td>
			<td>0.0</td>
			<td>0.0</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    LY # x 10^3/uL</td>
			<td>1.8</td>
			<td><br/>
			</td>
			<td>1.8</td>
			<td>1.3</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  ManualDifferential</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Granulocytes, immature %</td>
			<td>0</td>
			<td><br/>
			</td>
			<td>0</td>
			<td>1</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Lymphocyte %</td>
			<td>22</td>
			<td><br/>
			</td>
			<td>23</td>
			<td>21</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Monocyte %</td>
			<td>8</td>
			<td><br/>
			</td>
			<td>9</td>
			<td>8</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Eosinophil %</td>
			<td>1</td>
			<td><br/>
			</td>
			<td>1</td>
			<td>2</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Basophil %</td>
			<td>0</td>
			<td><br/>
			</td>
			<td>1</td>
			<td>1</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  Chemistries</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Glucose mg/dL</td>
			<td>124 (H)</td>
			<td><br/>
			</td>
			<td>122 (H)</td>
			<td>106 (H)</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    BUN mg/dL</td>
			<td>18</td>
			<td><br/>
			</td>
			<td>13</td>
			<td>15</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Creatinine mg/dL</td>
			<td>0.98</td>
			<td><br/>
			</td>
			<td>1.00</td>
			<td>0.84</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    BUN/Creatinine ratio</td>
			<td>18</td>
			<td><br/>
			</td>
			<td>13</td>
			<td>18</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Sodium mmol/L</td>
			<td>139</td>
			<td><br/>
			</td>
			<td>139</td>
			<td>136</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Potassium mmol/L</td>
			<td>4.1</td>
			<td><br/>
			</td>
			<td>4.0</td>
			<td>4.1</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Chloride mmol/L</td>
			<td>100</td>
			<td><br/>
			</td>
			<td>100</td>
			<td>100</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    CO2 mmol/L</td>
			<td>24</td>
			<td><br/>
			</td>
			<td>22</td>
			<td>22</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Calcium mg/dL</td>
			<td>9.5</td>
			<td><br/>
			</td>
			<td>9.4</td>
			<td>9.4</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Albumin g/dL</td>
			<td>4.6</td>
			<td><br/>
			</td>
			<td>4.5</td>
			<td>4.3</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Total protein g/dL</td>
			<td>6.6</td>
			<td><br/>
			</td>
			<td>6.9</td>
			<td>6.6</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Globulin g/dL</td>
			<td>2.0</td>
			<td><br/>
			</td>
			<td>2.4</td>
			<td>2.3</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    A/G ratio</td>
			<td>2.3 (H)</td>
			<td><br/>
			</td>
			<td>1.9</td>
			<td>1.9</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Bilirubin, total mg/dL</td>
			<td>1.1</td>
			<td><br/>
			</td>
			<td>0.8</td>
			<td>1.0</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Alkaline phosphatase, IU/L</td>
			<td>55</td>
			<td><br/>
			</td>
			<td>55</td>
			<td>58</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    AST/SGOT, IU/L</td>
			<td>22</td>
			<td><br/>
			</td>
			<td>23</td>
			<td>20</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    ALT/SGPT, IU/L</td>
			<td>22</td>
			<td><br/>
			</td>
			<td>21</td>
			<td>18</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    eGFR, mL/min/1.73</td>
			<td>82</td>
			<td><br/>
			</td>
			<td>80</td>
			<td>93</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  TumorMarkers</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Thyroglobulin ng/mL</td>
			<td><br/>
			</td>
			<td>3.9</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  Immunology</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Thyroglobulin ab, IU/mL</td>
			<td><br/>
			</td>
			<td>&lt;1</td>
			<td>&lt;1.0</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  Hormones</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    T3 uptake %</td>
			<td><br/>
			</td>
			<td>30</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Free thyroxine index</td>
			<td><br/>
			</td>
			<td>2.3</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    TSH uIU/mL</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td>4.200</td>
		</tr>
		<tr>
			<td>    TSH, mIU/L</td>
			<td><br/>
			</td>
			<td>3.61</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Thyroxine (T4) ug/dL</td>
			<td><br/>
			</td>
			<td>7.8</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  Pathology/Cytology</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<th align="left">  Lab - Other</th>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
		</tr>
		<tr>
			<td>    Lab Report</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td><br/>
			</td>
			<td>See attached</td>
			<td><br/>
			</td>
		</tr>
	</tbody>
</table>
<br/>
<br/>
<br/> IMAGING- <br/>
PET CT scan 12/17/2021 shows grossly enlarged right thyroid/right thyroid mass which on axial images measures up to 6.6 x 5.3 cm displacing the trachea rightward with moderate metabolic activity. Suspicious lymph nodes also noted in the right neck for example image #76 airway 2.3 x 2 cm lymph node with max SUV 3.9. No left-sided adenopathy. No other distant metastases or bone lesions.<br/>
<br/>
Nuclear medicine I-131 whole-body scan May 18, 2022: Normal<br/>
<br/>
<br/>PET CT scan  9/20/2022 showed no definite evidence of active malignancy on this study.
<br/>
US thyroid and CT neck in April 2023: thyroidectomy, no residual nodules or thyroid tissue<br/>
<br/>
<br/>
<br/> PATHOLOGY- <br/>
 thyroid mass biopsy on 11/17/2021.  The pathology showed tumor cells arranged in neoplastic follicles, with solid areas and scattered rare nuclear grooves.  TTF-1 is positive.  Findings consistent with follicular neoplasm including follicular carcinoma, follicular variant of papillary thyroid carcinoma and insular carcinoma.  <br/>
<br/>
<br/>
Pathology of the thyroid specimen 2/21/22  showed: Left thyroid mass thyroid parenchyma with cystic change, no malignancy. Right thyroid showed poorly differentiated thyroid carcinoma arising out of encapsulated papillary thyroid carcinoma, replacing entire right lobe of thyroid. Up to 11 cm in size, margins focally positive, 0 37 lymph nodes involved pathological T4 a N0. Right tracheal margin posterior showed peripheral thyroid carcinoma, right tracheal margin anterior also showed thyroid carcinoma, right tracheal resection margin showed thyroid carcinoma and right superior submucosal tracheal margin showed proliferative carcinoma. New anterior margin also showed a minute focus of poorly differentiated carcinoma. Also the other margins including the right new inferior, right superior margin, right inferior margin, new anterior inferior margin and new anterior inferior margin showed carcinoma. <br/>
<br/>
<br/>
<br/> PROCEDURES- <br/>
colonoscopy 8/17/23 reports normal<br/>
<br/>
<br/> DIRECTIVES- <br/>
{}<br/>
<br/>
<br/>
<br/> PROBLEMS LIST- <br/>

<ul><li>Primary malignant neoplasm of thyroid gland (disorder) ( ICD-10:C73 ;Malignant neoplasm of thyroid gland )</li><li>Hypothyroidism (disorder) ( ICD-10:E03.8 ;Other specified hypothyroidism )</li><li>Nausea and vomiting (disorder) ( ICD-10:R11.2 ;Nausea with vomiting, unspecified )</li><li>Obesity (disorder) ( ICD-10:E66.9 ;Obesity, unspecified )</li></ul>
<br/>



<br/> DIAGNOSTIC ASSESSMENT- <br/>
<ol><li>Right-sided thyroid mass, insidious onset, biopsy shows follicular neoplasm, thyroglobulin level 1988 in November 2021</li><li>s/p Pathology of the thyroid specimen 2/21/22  showed: Left thyroid mass thyroid parenchyma with cystic change, no malignancy. Right thyroid showed poorly differentiated thyroid carcinoma arising out of encapsulated papillary thyroid carcinoma, replacing entire right lobe of thyroid. Up to 11 cm in size, margins focally positive, 0 37 lymph nodes involved pathological T4 a N0. Right tracheal margin posterior showed peripheral thyroid carcinoma, right tracheal margin anterior also showed thyroid carcinoma, right tracheal resection margin showed thyroid carcinoma and right superior submucosal tracheal margin showed proliferative carcinoma. New anterior margin also showed a minute focus of poorly differentiated carcinoma. Also the other margins including the right new inferior, right superior margin, right inferior margin, new anterior inferior margin and new anterior inferior margin showed carcinoma.</li><li>s/p trach and removal </li><li>s/p RAI 5/11/22</li><li>PET CT DEP 20222 Negative</li><li>Obesity, hypertension, hyperlipidemia,</li><li>Atrial fibrillation  on Eliquis <br/>
	</li><li>Hypothyroidism; on Synthroid 100mcg per day <br/>
	</li><li> <br/>
	</li></ol>
<br/>
<br/>
<br/>
<br/> PLAN AND RECOMMENDATIONS- <br/>
<ol><li>I explained the condition, guarded/fair prognosis, plan of care and answered his questions. to the patient </li><li>Thank you for the referral </li><li>Noted CBC CMP thyroglobulin, TSH level and explained to the patient <br/>
	</li><li>We will see him back in 12 weeks, sooner if needed</li><li>FU Dr. Wang , ENT and with Dr. Toy, Radiation oncologist as warranted</li><li>Continue Synthroid 100 mcg per day; will adjust dose based on TSH level</li><li>PET scan as per Dr. Wang for restaging done in SEP 2022 negative</li><li>CT neck and US thyroid Arp 2023 Negative</li><li>will obtain imaging based on exam and thyroglobulin</li><li> <br/>
	</li></ol>
<br/>
<br/>
<br/>


<br/> NEW ORDERS- <br/>
Labs: None<br/>
Services: None<br/>


<br/>Imaging: None<br/>
Prescriptions: None<br/>


<br/>.<br/>
<br/>


<br/>HOLAVANAHALLI KESHAVA PRASAD, MD<br/>
<br/>


<br/>Send copy of note to: Beau James Toy, M.D.<br/>
Mailo Brantner, NP-C<br/>
Robert Wang, M.D.<br/>
<br/>
<br/>
<br/>
<br/>
<br/>

<br/>Electronically signed by Holavanahalli Keshava-Prasad MD 11/15/2023 12:13 PST 
		        </p>
		      </li></ul>
</div><br/><br/></body></html>